- Home
- BATRK vs ARWR Comparison
BATRK vs ARWR Comparison
Compare BATRK & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATRK
- ARWR
- Stock Information
- Founded
- BATRK 1991
- ARWR 2003
- Country
- BATRK United States
- ARWR United States
- Employees
- BATRK N/A
- ARWR N/A
- Industry
- BATRK Broadcasting
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- BATRK Industrials
- ARWR Health Care
- Exchange
- BATRK Nasdaq
- ARWR Nasdaq
- Market Cap
- BATRK 2.5B
- ARWR 2.5B
- IPO Year
- BATRK N/A
- ARWR 1993
- Fundamental
- Price
- BATRK $40.07
- ARWR $18.57
- Analyst Decision
- BATRK Strong Buy
- ARWR Buy
- Analyst Count
- BATRK 2
- ARWR 11
- Target Price
- BATRK $53.50
- ARWR $45.33
- AVG Volume (30 Days)
- BATRK 308.1K
- ARWR 997.3K
- Earning Date
- BATRK 11-06-2024
- ARWR 11-26-2024
- Dividend Yield
- BATRK N/A
- ARWR N/A
- EPS Growth
- BATRK N/A
- ARWR N/A
- EPS
- BATRK N/A
- ARWR N/A
- Revenue
- BATRK $678,378,000.00
- ARWR $19,648,000.00
- Revenue This Year
- BATRK $10.38
- ARWR N/A
- Revenue Next Year
- BATRK $5.23
- ARWR $100.95
- P/E Ratio
- BATRK N/A
- ARWR N/A
- Revenue Growth
- BATRK 5.31
- ARWR N/A
- 52 Week Low
- BATRK $35.42
- ARWR $17.05
- 52 Week High
- BATRK $44.43
- ARWR $39.83
- Technical
- Relative Strength Index (RSI)
- BATRK 46.89
- ARWR 35.87
- Support Level
- BATRK $40.24
- ARWR $21.20
- Resistance Level
- BATRK $42.51
- ARWR $22.03
- Average True Range (ATR)
- BATRK 1.04
- ARWR 0.87
- MACD
- BATRK 0.00
- ARWR -0.04
- Stochastic Oscillator
- BATRK 12.05
- ARWR 0.76
About BATRK Atlanta Braves Holdings Inc. Series C
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include, baseball which generates key revenue, and mixed-use development.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.